Skip to content
★ Sign in to follow
TL

Tamara L. Joseph

Directeur Juridique
Spero Therapeutics, Inc.Cubist Pharmaceuticals IncInvivo Therapeutics Holdings Corp.
Total declarations
29
Companies
3
▲ Purchases (0 ops.)
—
▼ Sales (4 ops.)
€702k

Latest filing published 05 Feb 2024 for Spero Therapeutics, Inc., €39k.

Filing timeline

BuySale
Tamara L. Joseph

Insider track record

Disclosed buys
0
Disclosed sells
4
Signal history

Tamara L. Joseph: trading record in brief

Tamara L. Joseph, listed as senior executive, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Cubist Pharmaceuticals Inc, Spero Therapeutics, Inc. and Invivo Therapeutics Holdings Corp. We count 29 filings; the first trade dates from 30 June 2008 and the latest from 2 February 2024.

The open-market record consists of 4 sales worth €702k, with no purchase. Other entries cover 5 share grants and 7 option exercises. 2024 to date brings no purchases and 1 sale.

On 5 February 2024 came the latest disclosure, an open-market sale for €39k in Spero Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Tamara L. Joseph

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations24 total

24 of 24 declarations